Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Becker

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Arzneimittel-Forschung|January 1, 1984
Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)B A Schölkens, R H Becker, J Kaiser
Annals of the New York Academy of Sciences|October 16, 2015
Redshift Evolution of Damped Lyman Alpha Absorbers and the Epoch of Galaxy FormationA L Kinney, R L White, R H Becker
Journal of Cardiovascular Pharmacology|January 1, 1991
Low-dose felodipine treatment attenuates endothelial dysfunction in rabbits fed an atherogenic dietR H Becker, W Linz, G Wiemer, et al.
British Journal of Clinical Pharmacology|October 1, 1986
Effect of captopril on changes in plasma noradrenaline induced by sodium nitroprussideR H Becker, A D Struthers, M J Brown
Science (New York, N.Y.)|November 9, 1973
Oceanic growth modelsR H Becker, C G Chase, E C Perry
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 24, 1998
Sustained diurnal blood pressure reduction in SHR with ramipril assessed by telemetric monitoringR H Becker, L Baldes, U Fürst, et al.
Hypertension (Dallas, Tex. : 1979)|October 1, 1991
Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykininG Wiemer, B A Schölkens, R H Becker, et al.
Arzneimittel-Forschung|September 1, 1988
General pharmacology of ramiprilM Omosu, I Komine, R H Becker, et al.
Bioorganic & Medicinal Chemistry|April 1, 1997
3N-methylbiphenylsulfonylurea and -carbamate substituted imidazo[4,5-b]pyridines. Potent antagonists of the ANG II AT1 receptorsH Heitsch, R H Becker, H W Kleemann, et al.
Strabismus|October 18, 2000
Preliminary report: examination of young children with Lea symbolsR H Becker, S H Hübsch, M H Gräf, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Arzneimittel-Forschung|January 1, 1984
Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)B A Schölkens, R H Becker, J Kaiser
Annals of the New York Academy of Sciences|October 16, 2015
Redshift Evolution of Damped Lyman Alpha Absorbers and the Epoch of Galaxy FormationA L Kinney, R L White, R H Becker
Journal of Cardiovascular Pharmacology|January 1, 1991
Low-dose felodipine treatment attenuates endothelial dysfunction in rabbits fed an atherogenic dietR H Becker, W Linz, G Wiemer, et al.
British Journal of Clinical Pharmacology|October 1, 1986
Effect of captopril on changes in plasma noradrenaline induced by sodium nitroprussideR H Becker, A D Struthers, M J Brown
Science (New York, N.Y.)|November 9, 1973
Oceanic growth modelsR H Becker, C G Chase, E C Perry
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 24, 1998
Sustained diurnal blood pressure reduction in SHR with ramipril assessed by telemetric monitoringR H Becker, L Baldes, U Fürst, et al.
Hypertension (Dallas, Tex. : 1979)|October 1, 1991
Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykininG Wiemer, B A Schölkens, R H Becker, et al.
Arzneimittel-Forschung|September 1, 1988
General pharmacology of ramiprilM Omosu, I Komine, R H Becker, et al.
Bioorganic & Medicinal Chemistry|April 1, 1997
3N-methylbiphenylsulfonylurea and -carbamate substituted imidazo[4,5-b]pyridines. Potent antagonists of the ANG II AT1 receptorsH Heitsch, R H Becker, H W Kleemann, et al.
Strabismus|October 18, 2000
Preliminary report: examination of young children with Lea symbolsR H Becker, S H Hübsch, M H Gräf, et al.
Pageof 3